FindTrial
Sign In

Guanxin V for coronary artery disease: a medical records based retrospective study

Guanxin V for coronary artery disease: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032241
Enrollment
Unknown
Registered
2020-04-24
Start date
2020-04-20
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

GXV group:GXV
GMT group:Convenience treatment

Sponsors

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults; 2. Meet the diagnostic criteria of CAD; 3. Meet the diagnostic criteria of Qi and Yin deficiency and blood stasis.

Exclusion criteria

Exclusion criteria: Continuation of any form of Chinese herbal medicines for 14 days before enrollment.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese medicine syndrome score;Heart function;Adverse events;—

Countries

China

Contacts

Public ContactNing Gu

Nanjing University of Chinese Medicine

jsguning@163.com+86 15181400995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026